![](https://endpts.com/wp-content/uploads/2024/05/American-Society-of-Gene-Cell-Therapy-ASGCT-2024-tile.jpg)
Photo: Lei Lei Wu for Endpoints News
Freeline unveils early efficacy signal for Gaucher gene therapy: #ASGCT24
BALTIMORE — Four patients with Gaucher disease were able to stop their regular treatments after receiving a one-time infusion of a gene therapy developed by Freeline …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.